NMR spectroscopic characterization of keto–enol equilibria of 1, 3-dimethyl-5-((4, 4-dimethyl-2,6-dioxocyclohexyl)(aryl)methyl)pyrimidine-2,4,6(1H,3H,5H)-trione in solution phase